The expression of PD‐L1 in the tumor microenvironment is often associated with tumor‐infiltrating lymphocytes (TILs), among which CD8‐positive (CD8+) TILs may be the most potent (Zhou et al., 2018). This evidence concerns the gene CD8A and neoplasm.